Table 1. Pharmacokinetic parameters of evocalcet after oral administration to male rats.
Dose | Cmax | tmax | AUC0-∞ | t1/2 | F | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
(mg/kg) | (ng/mL) | (h) | (ng⋅h/mL) | (h) | (%) | ||||||||
0.1 | 222.2 | ± | 19.8 | 0.25 | ± | 0.00 | 819 | ± | 262 | 6.66 | ± | 1.94 | 81.6 |
0.3 | 599.6 | ± | 59.8 | 0.38 | ± | 0.14 | 2578 | ± | 403 | 5.77 | ± | 0.33 | 85.6 |
1 | 2188 | ± | 291 | 0.81 | ± | 0.38 | 8445 | ± | 1108 | 6.13 | ± | 0.61 | 84.2 |
The mean ± S.D. n = 4/group. F, bioavailability